NCT03491046 is a NA clinical trial of PET scan in ACL Injury, sponsored by University of Cincinnati.

Who is sponsoring NCT03491046?

NCT03491046 is sponsored by University of Cincinnati.

What drugs are being tested in NCT03491046?

Interventions in NCT03491046: PET scan, MRI scan.

What condition does NCT03491046 study?

NCT03491046 studies ACL Injury.

Is NCT03491046 still recruiting?

NCT03491046 is currently status unknown. Last updated 18 January 2024.

Last reviewed 2024-01-18 · How we verify

NCT03491046

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Molecular Imaging Assessment of ACL Viability

Status unknown NA Last updated 18 January 2024

What this trial tests

NA trial testing PET scan in ACL Injury in 66 participants. Status unknown.

Timeline

9 October 2013

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	University of Cincinnati
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	66
Start date	9 October 2013
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	1 location across United States

Drugs / interventions tested

PET scan — full drug profile →
MRI scan

Conditions studied

ACL Injury — all drugs for ACL Injury →

Sponsor

University of Cincinnati

Who can join

Adults 18 to 60, any sex, with ACL Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to answer the following questions: 1. Does the appearance of the reconstructed anterior cruciate ligament (ACL) vary in appearance on PET/MRI depending on graft type and time after surgery? 2. What is the appearance of the native ACL on Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI)?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of PET scan

Trials testing the same drug.

NCT07367815 — Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease · Phase 1, PHASE2 · not yet recruiting
NCT06398392 — Radiation Dosimetry of the 18 kDa Translocator Protein Ligand [18F]PBR111 in Humans · NA · completed
NCT05012098 — Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON). · Phase 2 · completed
NCT04101968 — The GBA Multimodal Study in Parkinson's Disease · recruiting
NCT03554473 — M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers · Phase 1, PHASE2 · completed

Other recruiting trials for ACL Injury

Currently open trials in the same condition.

NCT06529679 — Michigan Split-belt Treadmill Training Program to Improve Acute Knee Biomechanics After ACL Reconstruction · NA · recruiting
NCT06442319 — The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction. · NA · recruiting
NCT06524869 — Association Between Neuromuscular Parameters and Functional Assessment After ACL Reconstruction · recruiting
NCT07387939 — ACL Reconstruction in Patients Aged 50 Years and Older · active not recruiting
NCT06194682 — Anterior Cruciate Ligament Study · recruiting

Other University of Cincinnati trials

Trials by the same sponsor.

NCT05605366 — Minocycline In Neurocognitive Outcomes - Sickle Cell Disease · Phase 1 · not yet recruiting
NCT07528638 — Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND) · NA · not yet recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07447895 — Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies · NA · not yet recruiting
NCT07231588 — Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation · EARLY_PHASE1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03491046 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Cincinnati
Last refreshed: 18 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03491046.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing